Bausch Health Companies Inc (NYSE: BHC) has seen a rise in its stock price by 2.23 in relation to its previous close of 4.48. However, the company has experienced a -0.22% decline in its stock price over the last five trading sessions. zacks.com reported 2025-05-30 that Bausch (BHC) reported earnings 30 days ago. What’s next for the stock?
Is It Worth Investing in Bausch Health Companies Inc (NYSE: BHC) Right Now?
Moreover, the 36-month beta value for BHC is 0.28. Analysts have varying opinions on the stock, with 0 analysts rating it as a “buy,” 1 as “overweight,” 5 as “hold,” and 0 as “sell.”
The public float for BHC is 291.10M and currently, short sellers hold a 2.81% of that float. On June 04, 2025, BHC’s average trading volume was 2.04M shares.
BHC’s Market Performance
BHC’s stock has seen a -0.22% decrease for the week, with a -15.50% drop in the past month and a -34.66% fall in the past quarter. The volatility ratio for the week is 1.90%, and the volatility levels for the past 30 days are at 2.21% for Bausch Health Companies Inc The simple moving average for the last 20 days is -0.54% for BHC stock, with a simple moving average of -33.99% for the last 200 days.
Analysts’ Opinion of BHC
Many brokerage firms have already submitted their reports for BHC stocks, with Piper Sandler repeating the rating for BHC by listing it as a “Underweight.” The predicted price for BHC in the upcoming period, according to Piper Sandler is $3 based on the research report published on August 02, 2024 of the previous year 2024.
Raymond James, on the other hand, stated in their research note that they expect to see BHC reach a price target of $8. The rating they have provided for BHC stocks is “Mkt Perform” according to the report published on July 10th, 2024.
Jefferies gave a rating of “Buy” to BHC, setting the target price at $16 in the report published on September 20th of the previous year.
BHC Trading at -10.67% from the 50-Day Moving Average
After a stumble in the market that brought BHC to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -53.50% of loss for the given period.
Insider Trading
Reports are indicating that there were more than several insider trading activities at BHC starting from Carson Seana, who sale 440 shares at the price of $8.35 back on Dec 02 ’24. After this action, Carson Seana now owns 433,066 shares of Bausch Health Companies Inc, valued at $3,674 using the latest closing price.
Carson Seana, the Officer of Bausch Health Companies Inc, proposed sale 440 shares at $8.35 during a trade that took place back on Dec 02 ’24, which means that Carson Seana is holding shares at $3,674 based on the most recent closing price.
Stock Fundamentals for BHC
Current profitability levels for the company are sitting at:
- 0.16 for the present operating margin
- 0.65 for the gross margin
The net margin for Bausch Health Companies Inc stands at -0.0. The total capital return value is set at 0.06.
Currently, EBITDA for the company is 1.55 billion with net debt to EBITDA at -0.45. When we switch over and look at the enterprise to sales, we see a ratio of 0.06. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.35.
Conclusion
To wrap up, the performance of Bausch Health Companies Inc (BHC) has been bad in recent times. The stock has received a mixed of “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
